Validation of the Zwolle Risk Score in STEMI Patients Undergoing Primary PCI: Insights from the ISCAS-STEMI COVID-19 Registry.
De Luca G, Algowhary M, Uguz B, Oliveira DC, Ganyukov V, Zimbakov Z, Cercek M, Jensen LO, Huan Loh P, Calmac L, Roura I Ferrer G, Quadros A, MIlewski M, Di Uccio FS, Von Birgelen C, Versaci F, Ten Berg J, Casella G, Wong Sung Lung A, Kala P, Díez Gil JL, Carrillo X, Dirksen MT, Manuel Becerra-Munoz V, Kang-Yin Lee M, Arifa Juzar D, de Moura Joaquim R, Paladino R, Milicic D, Davlouros P, Bakraceski N, Zilio F, Donazzan L, Kraaijeveld A, Galasso G, Arpad L, Marinucci L, Guiducci V, Menichelli M, Scoccia A, Hatice Yamac A, Ugur Mert K, Rios XF, Kovarnik T, Kidawa M, Moreu J, Vincent F, Fabris E, Martinez-Luengas IL, Boccalatte M, Bosa Ojeda F, Arellano-Serrano C, Caiazzo G, Cirrincione G, Kao HL, Sanchis Fores J, Vignali L, Pereira H, Manzo-Silbermann S, Ordonez S, Arat Ozkan A, Scheller B, Lehtola H, Teles R, Mantis C, Antti Y, Brum Silveira JA, Zoni R, Bessonov I, Savonitto S, Kochiadakis G, Alexopoulos D, Uribe CE, Kanakakis J, Faurie B, Gabrielli G, Gutierrez Barrios A, Bachini JP, Rocha A, Chor-Cheung Tam F, Rodriguez A, Lukito AA, Saint-Joy V, Pessah G, Cortese G, Parodi G, Burgadha MA, Kedhi E, Lamelas P, Suryapranata H, Nardin M, Verdoia M.
De Luca G, et al. Among authors: fabris e.
Curr Vasc Pharmacol. 2026;24(1):68-75. doi: 10.2174/0115701611335913250408214530.
Curr Vasc Pharmacol. 2026.
PMID: 40247796